相似文献
1
Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13813-8. doi: 10.1073/pnas.212511599. Epub 2002 Oct 7.
2
Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
J Virol. 2003 Dec;77(24):13042-52. doi: 10.1128/jvi.77.24.13042-13052.2003.
3
The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys.
J Leukoc Biol. 2003 Nov;74(5):772-80. doi: 10.1189/jlb.0503196.
4
Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
Vaccine. 2002 May 6;20(15):1934-7. doi: 10.1016/s0264-410x(02)00072-5.
5
Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.
AIDS Res Hum Retroviruses. 2004 Jan;20(1):27-40. doi: 10.1089/088922204322749477.
6
Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing.
J Infect Dis. 1997 Aug;176(2):362-73. doi: 10.1086/514053.
7
Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
J Virol. 2001 Jun;75(12):5646-55. doi: 10.1128/JVI.75.12.5646-5655.2001.
8
A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.
J Virol. 1996 Oct;70(10):6922-8. doi: 10.1128/JVI.70.10.6922-6928.1996.
9
Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7490-4. doi: 10.1073/pnas.92.16.7490.
10
Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
Virology. 1995 Nov 10;213(2):600-14. doi: 10.1006/viro.1995.0032.
引用本文的文献
1
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia.
J Exp Med. 2021 Jan 4;218(1). doi: 10.1084/jem.20201214.
2
Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitor.
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22436-22442. doi: 10.1073/pnas.2009700117. Epub 2020 Aug 20.
3
The Expression of Functional Vpx during Pathogenic SIVmac Infections of Rhesus Macaques Suppresses SAMHD1 in CD4+ Memory T Cells.
PLoS Pathog. 2015 May 21;11(5):e1004928. doi: 10.1371/journal.ppat.1004928. eCollection 2015 May.
4
Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.
J Virol. 2014 May;88(9):5014-28. doi: 10.1128/JVI.02785-13. Epub 2014 Feb 19.
5
Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains.
Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19769-74. doi: 10.1073/pnas.1217443109. Epub 2012 Nov 5.
6
Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo.
J Virol. 2011 Oct;85(19):9708-15. doi: 10.1128/JVI.00626-11. Epub 2011 Jul 20.
7
Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques.
J Virol. 2010 May;84(9):4769-81. doi: 10.1128/JVI.02279-09. Epub 2010 Feb 10.
8
Enantiomeric radiochemical synthesis of R and S (1-(6-amino-9H-purin-9-yl)-3-fluoropropan-2-yloxy)methylphosphonic acid (FPMPA).
J Labelled Comp Radiopharm. 2008 Mar 13;51(4):187-194. doi: 10.1002/jlcr.1505.
9
Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.
AIDS Res Hum Retroviruses. 2009 Jan;25(1):45-55. doi: 10.1089/aid.2008.0111.
10
Although macrophage-tropic simian/human immunodeficiency viruses can exhibit a range of pathogenic phenotypes, a majority of isolates induce no clinical disease in immunocompetent macaques.
J Virol. 2007 Oct;81(19):10669-79. doi: 10.1128/JVI.00517-07. Epub 2007 Jul 11.
本文引用的文献
1
CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity.
J Virol. 2002 Mar;76(6):2595-605. doi: 10.1128/jvi.76.6.2595-2605.2002.
2
Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous.
J Virol. 2002 Jan;76(1):379-91. doi: 10.1128/jvi.76.1.379-391.2002.
3
Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates.
AIDS Res Hum Retroviruses. 2001 Oct 10;17(15):1405-14. doi: 10.1089/088922201753197079.
4
Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
J Virol. 2001 Apr;75(8):3903-15. doi: 10.1128/JVI.75.8.3903-3915.2001.
5
Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops.
J Virol. 2001 Apr;75(7):3435-43. doi: 10.1128/JVI.75.7.3435-3443.2001.
6
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans.
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):658-63. doi: 10.1073/pnas.98.2.658. Epub 2001 Jan 2.
7
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.
J Infect Dis. 2001 Jan 1;183(1):36-50. doi: 10.1086/317641. Epub 2000 Dec 8.
8
The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.
J Virol. 2000 Dec;74(23):10984-93. doi: 10.1128/jvi.74.23.10984-10993.2000.
9
Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-->Gly) at codon 69.
J Virol. 2000 Dec;74(23):10958-64. doi: 10.1128/jvi.74.23.10958-10964.2000.
10
Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages.
J Virol. 2000 Nov;74(22):10852-9. doi: 10.1128/jvi.74.22.10852-10859.2000.
Zotero 插件